JP2023552368A5 - - Google Patents
Info
- Publication number
- JP2023552368A5 JP2023552368A5 JP2023533819A JP2023533819A JP2023552368A5 JP 2023552368 A5 JP2023552368 A5 JP 2023552368A5 JP 2023533819 A JP2023533819 A JP 2023533819A JP 2023533819 A JP2023533819 A JP 2023533819A JP 2023552368 A5 JP2023552368 A5 JP 2023552368A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- composition according
- formula
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121674P | 2020-12-04 | 2020-12-04 | |
| US63/121,674 | 2020-12-04 | ||
| US202163256609P | 2021-10-17 | 2021-10-17 | |
| US63/256,609 | 2021-10-17 | ||
| PCT/US2021/061906 WO2022120242A1 (en) | 2020-12-04 | 2021-12-03 | Y box binding protein 1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552368A JP2023552368A (ja) | 2023-12-15 |
| JP2023552368A5 true JP2023552368A5 (https=) | 2024-11-29 |
Family
ID=81853609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533819A Pending JP2023552368A (ja) | 2020-12-04 | 2021-12-03 | Ｙボックス結合タンパク質１阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240016784A1 (https=) |
| EP (1) | EP4255426A4 (https=) |
| JP (1) | JP2023552368A (https=) |
| AU (1) | AU2021391931A1 (https=) |
| CA (1) | CA3201032A1 (https=) |
| WO (1) | WO2022120242A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4554587A2 (en) * | 2022-07-12 | 2025-05-21 | Oregon Health & Science University | Enantiomer of azopodophyllotoxin derivative su056 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170342086A1 (en) * | 2015-02-26 | 2017-11-30 | Ajay Kumar | Compounds and methods for the treatment of drug resistance in cancer cells against paclitaxel |
| US11098052B2 (en) * | 2016-03-02 | 2021-08-24 | Arizona Board Of Regents On Behalf Of Arizona State University | 4-azapodophylotoxins compounds |
| US11771692B2 (en) * | 2018-03-13 | 2023-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | N-hydroxyethyl didehydroazapodophyllotoxins as GBP1 inhibitors and methods of overcoming treatment resistance in cancer |
| CN116761602A (zh) * | 2020-12-04 | 2023-09-15 | 俄勒冈健康与科学大学 | Y盒结合蛋白质1抑制剂 |
-
2021
- 2021-12-03 JP JP2023533819A patent/JP2023552368A/ja active Pending
- 2021-12-03 CA CA3201032A patent/CA3201032A1/en active Pending
- 2021-12-03 AU AU2021391931A patent/AU2021391931A1/en active Pending
- 2021-12-03 US US18/255,827 patent/US20240016784A1/en active Pending
- 2021-12-03 WO PCT/US2021/061906 patent/WO2022120242A1/en not_active Ceased
- 2021-12-03 EP EP21901582.3A patent/EP4255426A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230118795A1 (en) | Aryl or heteroaryl pyridone or pyrimidine derivative, preparation method and use thereof | |
| JP2022020003A5 (https=) | ||
| ES2823477T3 (es) | Aril éteres y usos de los mismos | |
| HRP20160625T1 (hr) | Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka | |
| JP2024514338A5 (https=) | ||
| JP2020517616A5 (https=) | ||
| JP2010539095A5 (https=) | ||
| CN114430739A (zh) | Egfr抑制剂、组合物及其制备方法 | |
| JP2019535746A5 (https=) | ||
| CN115244058A (zh) | 嘧啶并二环类衍生物、其制备方法及其在医药上的应用 | |
| JP2021523159A5 (https=) | ||
| RU2013156074A (ru) | Диазакарбазолы и способы применения | |
| CN114430741A (zh) | Egfr抑制剂、组合物及其制备方法 | |
| RU2010128107A (ru) | Лечение рака ингибиторами топоизомеразы в комбинации с ингибиторами parp | |
| CN107548391A (zh) | 嘧啶或吡啶类化合物、其制备方法和医药用途 | |
| HRP20240392T1 (hr) | 6,7-dihidro-5h-pirido[2,3-c] derivati piridazina i srodni spojevi kao inhibitori bcl-xl proteina i pro-apoptozna sredstva za liječenje raka | |
| RU2015101106A (ru) | Способ лечения лимфомы, применяя тиенотриазолодиазепиновые соединения | |
| RU2014119339A (ru) | 2-КАРБОКСАМИД ЦИКЛОАМИНО ПРОИЗВОДНЫЕ МОЧЕВИНЫ В КОМБИНАЦИИ С ИНГИБИТОРАМИ Hsp90 ДЛЯ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ | |
| JP2023531709A5 (https=) | ||
| KR20020073589A (ko) | 축합 이미다졸륨 유도체 | |
| JP2023502458A5 (https=) | ||
| JP2022534704A5 (https=) | ||
| CN111511745A (zh) | 吡唑并[1,5-a][1,3,5]三嗪-2-胺类衍生物、其制备方法及其在医药上的应用 | |
| IL319246A (en) | Isoquinolones as PI3K inhibitors | |
| JPWO2020032105A5 (https=) |